News

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Usha Lee McFarling ...
Novartis is buying Regulus for $800 million, picking up the biotech's experimental kidney drug that's based off a ...
In a significant move, the NIH said it would reduce its reliance on animals in federally funded research and instead ...
Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...
Lack of clarity from officials delay providers' efforts to ensure clinical decision support tools don't discriminate.
Twenty years after the debates of the George W. Bush era, there appears to be a serious threat that all government human ...
The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...
As medical schools struggle to source cadavers ethically and affordably, many are turning to technology instead. That, one ...
We’d like to introduce you to the fellow above, whose name is Jae. When asked what area of study she specializes in, she only ...
FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.
If the law is struck down or any ambiguity left surrounding its validity, coverage of and access to preventive care like PrEP ...
Funding for a landmark health study, the Women's Health Initiative, was cut then reportedly restored, but researchers are ...